Share the post "NGL Fine-Chem announced Financial Results Q1 2024"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 27.75 % in the past year, decrease in net sales/revenue by -9.03 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 77.15 %. Marginal increase in other income during this quarter, up by 59.92%.
- Profit over the Year and quarter: Significant improvement in profitability for NGL Fine-Chem Limited. Notable increase of 8.37 % in net profit Year to Year, NGL Fine-Chem Limited’s profitability dropped by -25.2 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 8.35 % Year to Year. EPS decreased by -25.21 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 71.042 Cr | Rs. 99.761 Cr | Rs. 90.754 Cr | -9.03 % | + 27.75 % |
Expenses | Rs. 61.18 Cr | Rs. 83.94 Cr | Rs. 81.41 Cr | -3.01 % | + 33.07 % |
Operating Profit | Rs. 9.86 Cr | Rs. 15.82 Cr | Rs. 9.34 Cr | -40.96 % | -5.27 % |
OPM % | 13.88 % | 15.86 % | 10.29 % | -5.57 % | -3.59 % |
Other Income | Rs. 3.322 Cr | Rs. 3.68 Cr | Rs. 5.885 Cr | + 59.92 % | + 77.15 % |
Interest | Rs. 0.24 Cr | Rs. 0.49 Cr | Rs. 0.44 Cr | -10.2 % | + 83.33 % |
Depreciation | Rs. 2.86 Cr | Rs. 2.92 Cr | Rs. 3.01 Cr | + 3.08 % | + 5.24 % |
Profit before tax | Rs. 10.08 Cr | Rs. 16.09 Cr | Rs. 11.78 Cr | -26.79 % | + 16.87 % |
Tax % | 15.64 % | 23.42 % | 21.79 % | -1.63 % | + 6.15 % |
Net Profit | Rs. 8.51 Cr | Rs. 12.33 Cr | Rs. 9.22 Cr | -25.22 % | + 8.34 % |
EPS in Rs | Rs. 13.77 | Rs. 19.95 | Rs. 14.92 | -25.21 % | + 8.35 % |
Today, we’re looking at NGL Fine-Chem Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 27.75 %. However, it did see a marginal slip of -9.03 % from the previous quarter. Expenses decreased slightly by -3.01 % quarter-on-quarter, aligning with the annual rise of 33.07 %. Operating profit, while down -5.27 % compared to last year, faced a quarter-on-quarter dip of -40.96 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.59 %, but a shrinkage of -5.57 % sequentially. Other income rose by 59.92 % compared to the last quarter, despite an annual growth of 77.15 %. Interest expenses dropped significantly by -10.2 % from the previous quarter, yet the year-over-year increase remains at a moderate 83.33 %. Depreciation costs climbed by 3.08 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 5.24 %. Profit before tax grew annually by 16.87 % but saw a reduction from the preceding quarter by -26.79 %.
Tax expenses as a percentage of profits increased slightly by 6.15 % compared to last year, with a more notable quarter-on-quarter decrease of -1.63 %. Net profit rose by 8.34 % year-on-year but witnessed a -25.22 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 8.35 % but a quarterly fall of -25.21 %. In summary, NGL Fine-Chem Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 71.042 Cr | Rs. 99.761 Cr | Rs. 90.754 Cr | -9.03 % | + 27.75 % |
Expenses | Rs. 61.18 Cr | Rs. 83.94 Cr | Rs. 81.41 Cr | -3.01 % | + 33.07 % |
Operating Profit | Rs. 9.86 Cr | Rs. 15.82 Cr | Rs. 9.34 Cr | -40.96 % | -5.27 % |
Net Profit | Rs. 8.51 Cr | Rs. 12.33 Cr | Rs. 9.22 Cr | -25.22 % | + 8.34 % |
EPS in Rs | Rs. 13.77 | Rs. 19.95 | Rs. 14.92 | -25.21 % | + 8.35 % |
In reviewing NGL Fine-Chem Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 27.75 % year-on-year growth, although there was a slight dip of -9.03 % from the previous quarter. Expenses rose by 33.07 % compared to the previous year, with a decrease of -3.01 % quarter-on-quarter. Operating Profit dropped by -5.27 % annually, and saw a -40.96 % decrease from the last quarter.
Net Profit showed yearly increase of 8.34 %, and experienced a -25.22 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 8.35 % annually, however dipped by -25.21 % compared to the last quarter. In essence, while NGL Fine-Chem Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
-11
3-Year Profit
14
5-Year Profit
23
10-Year Profit
1,989
Current Price
1,229
Market Cap
In analyzing the financial results for the company marked by BSE code 524774, a clear trend emerges. Over a five-year span, the company reported a profit of 14 percents, which increased to -11 percents in the most recent three-year period, suggesting a strong performance in the early stages of this timeframe. However, this success has been overshadowed by a trailing twelve-month (TTM) loss of 13 percents, signaling significant recent challenges. Compounding this issue is the fact that the company has not reported any sales during any of the timeframes analyzed, raising important questions about its operational model and the sustainability of its current strategies. Investors have been equally wary, as reflected in the stock price performance. The company’s stock traded at 33 percents over the past five years but has recently decreased to -1 percents, indicating a loss of market confidence. Over the last decade, the stock price was at 41 percents, pointing to longer-term concerns that could affect the company's future prospects.
Currently valued at ₹1,229 crore, the company's stock price stands at ₹1,989. Over the years, it has seen significant fluctuations, with its price ranging from ₹2,824 / 1,773, a reflection of its sensitivity to market conditions and investor sentiment. The stock's Price-to-Earnings (P/E) ratio, currently at 29.7, suggests that it is highly valued in comparison to its earnings, possibly indicating strong future growth expectations or a high level of investor confidence. The book value per share is ₹454, which represents the net asset value of the company per share. The dividend yield of 0.09% provides some return to investors, though it may not be the primary attraction for those investing in the stock. The company's Return on Capital Employed (ROCE) is 20.4%, pointing to efficient use of its capital base to generate profits. The Return on Equity (ROE), at 17.0%, highlights the profitability for shareholders. The company's financial health is further underscored by its very low debt-to-equity ratio of 0.18, signaling conservative financial management. However, the net cash flow is negative at ₹-7.43 crore, indicating possible liquidity concerns or heavy investment. The Piotroski score of 7.00 provides a snapshot of its financial stability, while the Graham Number, estimated at ₹827, offers an intrinsic value benchmark. With a Price-to-Book (P/B) ratio of 4.38, the stock seems to be trading at a premium relative to its book value, which could signal strong market expectations or overvaluation risks.